TGF-β signaling activated in marrow stromal cells has been hypothesized to drive the progression of Philadelphia translocation (Ph)-negative myeloproliferative neoplasms (MPN) to PMF43,45. The gene discussed is TGFB1; the disease is myeloproliferative neoplasm.